XTLB

XTL Biopharmaceuticals
XTLB

3 hedge funds and large institutions have $293K invested in XTL Biopharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$363

Top Sellers

1
-$2.78K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$241K
2
$52K
3
$363